E N D
1. Cancer Prevention Monica M. Bertagnolli, MD
Brigham and Women’s Hospital
Dana Farber Cancer Institute
3. Milestones in cancer prevention 1919 James Ewing identifies pre-malignant neoplasia
4. Milestones in cancer prevention
5. Cancer Prevention Research
7. Invasive cancer is the end stage of a long process of tumorigenesis
11. Understanding the biology of pre-malignant disease is the key to developing effective prevention methods Which individuals are at risk and for what type of cancer?
12. Understanding Risk
14. Understanding Risk for Cancer Environment:
Toxic exposures
Radiation
Asbestos
15. Colorectal Cancer Risk
Personal history
Identification of adenomas
Inflammatory bowel disease
History of treated colorectal cancer
16. Identifying and monitoring pre-malignant disease
17. Survival following treatment for colorectal cancer
18. Shifting the therapeutic target in breast cancer 1894 Halsted radical mastectomy
1960’s-70’s breast conserving surgery with XRT
1919 James Ewing “pre-malignant histology”
1932 Broder “carcinoma-in-situ”
1979 2,600 cases of DCIS in the US
2000 30,000 cases of DCIS in the US
20. Screening modalities 2007 PAP smear
Mammography
Colonoscopy/upper endoscopy
CT scan, sputum cytologies
PSA and digital exam
21. Risk Specific CRC Screening Recommendations Begin at age 50:
Colonoscopy every 10 years
Sigmoidoscopy every 5 years
Annual FOBT (stool sample)
22. Prevention Modalities
25. Surgery
29. Prevention of breast cancer by treatment of DCIS 30,000 US women per year diagnosed with DCIS in the US
31. Successes and Challenges Breast cancer: tamoxifen
Prostate cancer: finasteride
Colorectal cancer: celecoxib
Women’s Health Initiative
Cervical cancer vaccine
32. Breast Cancer Prevention Trial
34. Prostate Cancer Prevention Trial
45. Vaccination against human papilloma virus HPV infection is associated with development of cervical cancer and other anogenital tumors